International Scholarly Research Notices

Clinical Study

Parameters of Blood Count and Tumor Markers in Patients with Borderline Ovarian Tumors: A Retrospective Analysis and Relation to Staging

Table 2

Tumor markers (mean ± standard deviation) in serous histological subtypes ( 𝑛 = 8 ) and nonserous ( 𝑛 = 1 3 ) borderline ovarian tumors.
Serous Mean ± standard deviationNonserous Mean ± standard deviation
CA-125 (U/mL) 4 4 . 8 7 ± 5 9 . 9 9 7 5 . 1 9 ± 1 3 6 . 7 1
CA-15.3 (U/mL) 5 3 . 6 6 ± 6 2 . 3 2 3 . 1 9 ± 1 1 . 3 1
CA-19.9 (U/mL) 7 . 0 1 ± 5 . 0 1 2 4 . 9 5 ± 2 9 . 3 8
CEA (U/mL) 1 . 3 1 ± 1 . 2 2 7 . 6 7 ± 1 0 . 3 1
AFP (U/mL) 1 . 7 4 ± 0 . 6 2 1 . 2 4 ± 0 . 5 4
Unpaired 𝑡 -test; 𝑃 ∶ not significant.